146 related articles for article (PubMed ID: 10390253)
21. Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population.
Bonsignori F; Chiappini E; Frenos S; Peraldo M; Galli L; de Martino M
Infection; 2007 Dec; 35(6):444-50. PubMed ID: 18034210
[TBL] [Abstract][Full Text] [Related]
22. Economic burden of surgically confirmed endometriosis in Canada.
Levy AR; Osenenko KM; Lozano-Ortega G; Sambrook R; Jeddi M; Bélisle S; Reid RL
J Obstet Gynaecol Can; 2011 Aug; 33(8):830-837. PubMed ID: 21846438
[TBL] [Abstract][Full Text] [Related]
23. Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.
Wysocki J; Malecka I; Stryczynska-Kazubska J; Rampakakis E; Kuter B; Wolfson LJ
BMC Public Health; 2018 Mar; 18(1):410. PubMed ID: 29587714
[TBL] [Abstract][Full Text] [Related]
24. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
25. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
Iragorri N; de Oliveira C; Fitzgerald N; Essue B
Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
[TBL] [Abstract][Full Text] [Related]
26. Chickenpox vaccination, not chickenpox, should be routine for Canadian children.
Law BJ
CMAJ; 2001 May; 164(10):1454-5. PubMed ID: 11387920
[No Abstract] [Full Text] [Related]
27. [Clinical and cost characterization of hospitalization associated with varicella in children from the Metropolitan Region and Valparaíso, Chile].
Torres JP; Maza V; Izquierdo G; Contardo V; Conca N; Ducasse K; Castro M
Rev Chilena Infectol; 2021 Oct; 38(5):647-654. PubMed ID: 35506831
[TBL] [Abstract][Full Text] [Related]
28. Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015.
Meszner Z; Molnar Z; Rampakakis E; Yang HK; Kuter BJ; Wolfson LJ
BMC Infect Dis; 2017 Jul; 17(1):495. PubMed ID: 28705150
[TBL] [Abstract][Full Text] [Related]
29. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
30. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008.
Tan B; Bettinger J; McConnell A; Scheifele D; Halperin S; Vaudry W; Law B;
Pediatr Infect Dis J; 2012 Sep; 31(9):956-63. PubMed ID: 22647896
[TBL] [Abstract][Full Text] [Related]
31. Economic burden of varicella in Europe in the absence of universal varicella vaccination.
Pawaskar M; Méroc E; Samant S; Flem E; Bencina G; Riera-Montes M; Heininger U
BMC Public Health; 2021 Dec; 21(1):2312. PubMed ID: 34930179
[TBL] [Abstract][Full Text] [Related]
32. The cost of childhood chickenpox: parents' perspective.
Lieu TA; Black SB; Rieser N; Ray P; Lewis EM; Shinefield HR
Pediatr Infect Dis J; 1994 Mar; 13(3):173-7. PubMed ID: 8177622
[TBL] [Abstract][Full Text] [Related]
33. Impact of chickenpox on households of healthy children.
Sullivan-Bolyai JZ; Yin EK; Cox P; Marchand A; Meissinger J; Venerable L; Weiss B
Pediatr Infect Dis J; 1987 Jan; 6(1):33-5. PubMed ID: 3822615
[TBL] [Abstract][Full Text] [Related]
34. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.
Ehlken B; Ihorst G; Lippert B; Rohwedder A; Petersen G; Schumacher M; Forster J;
Eur J Pediatr; 2005 Oct; 164(10):607-15. PubMed ID: 15965766
[TBL] [Abstract][Full Text] [Related]
35. Morbidity and cost of vaccine-preventable varicella in previously healthy children in Arkansas.
Markham MH; Darville T
J Ark Med Soc; 1999 Dec; 96(7):260-2. PubMed ID: 10628121
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
37. Severe complications of varicella in previously healthy children in Germany: a 1-year survey.
Ziebold C; von Kries R; Lang R; Weigl J; Schmitt HJ
Pediatrics; 2001 Nov; 108(5):E79. PubMed ID: 11694663
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
[TBL] [Abstract][Full Text] [Related]
40. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
